Company Valuation: eFFECTOR Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023
Market Cap 1 334.3 17.91 30.2
Change - -94.64% 68.61%
Enterprise Value (EV) 1 304.6 11.88 32.38
Change - -96.1% 172.45%
P/E 18.8x -0.78x -0.71x
PBR 19.3x 4.58x -6.01x
PEG 0x 0x -0x
Capitalization / Revenue 233,760,757x 5,041,796x -
EV / Revenue - - -
EV / EBITDA -9.56x -0.37x -0.96x
EV / EBIT -9.55x -0.37x -0.96x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 11 -13.76 -16.37
Distribution rate - - -
Net sales 1.43 3.553 -
EBITDA 1 -31.87 -32.35 -33.73
EBIT 1 -31.9 -32.4 -33.84
Net income 1 15.8 -22.66 -35.81
Net Debt 1 -29.67 -6.029 2.175
Reference price 2 207.000000 10.690000 11.685000
Nbr of stocks (in thousands) 1,615 1,676 2,585
Announcement Date 3/16/22 A 3/8/23 A 3/26/24 A
1USD in Million2USD
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
21.25x6.51x14.24x1.5% 56.54B
31.6x7.8x24.02x0.05% 53.6B
-17.91x4.18x-7.32x-.--% 22.91B
-38.06x12.21x-36.05x-.--% 21.37B
25.45x4.98x13.18x-.--% 20.27B
24.28x4.73x15.36x-.--% 17.56B
-737.38x35.03x-3943.97x-.--% 14.75B
40.7x16.37x42.16x0.09% 13.53B
16.73x4.82x11.24x-.--% 13.33B
Average -70.37x 10.74x -429.68x 0.18% 25.98B
Weighted average by Cap. -32.01x 9.11x -238.39x 0.38%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. EFTR Stock
  4. LWK Stock
  5. Valuation eFFECTOR Therapeutics, Inc.